Co-Authors
This is a "connection" page, showing publications co-authored by NICOLA HANANIA and FERNANDO MARTINEZ.
Connection Strength
1.317
-
Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment Trial. Chest. 2021 03; 159(3):985-995.
Score: 0.188
-
Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD. ERJ Open Res. 2020 Apr; 6(2).
Score: 0.182
-
Confronting the Challenge of COPD: What Is New in the Approaches to Diagnosis, Treatment, and Patient Outcomes. Chest. 2018 10; 154(4):984-985.
Score: 0.163
-
Clinical Approach to the Therapy of Asthma-COPD Overlap. Chest. 2019 01; 155(1):168-177.
Score: 0.161
-
Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ). Respir Med. 2010 Aug; 104(8):1160-70.
Score: 0.090
-
Development and validation of the Chronic Obstructive Pulmonary Disease Assessment Questionnaire (COPD-AQ). Prim Care Respir J. 2009 Sep; 18(3):198-207.
Score: 0.087
-
Dual-combination maintenance inhaler preferences in asthma and chronic obstructive pulmonary disease: A patient-centered benefit-risk assessment. Respir Med. 2021 01; 176:106278.
Score: 0.047
-
Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experiment. Thorax. 2020 09; 75(9):735-743.
Score: 0.046
-
COPDGene? 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease. Chronic Obstr Pulm Dis. 2019 Nov; 6(5):384-399.
Score: 0.044
-
Erratum: Erratum: Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension? Delivery Technology Versus Foradil? Aerolizer? in Moderate-To-Severe COPD: A Randomized, Dose-Ranging Study. Chronic Obstr Pulm Dis. 2017 Apr 15; 4(3):258.
Score: 0.037
-
Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension? Delivery Technology Versus Foradil? Aerolizer? in Moderate-To-Severe COPD: A Randomized, Dose-Ranging Study. Chronic Obstr Pulm Dis. 2016 Nov 17; 4(1):21-33.
Score: 0.036
-
Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus. Chronic Obstr Pulm Dis. 2016 Nov 15; 4(1):7-20.
Score: 0.036
-
Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD. PLoS Genet. 2016 Aug; 12(8):e1006011.
Score: 0.035
-
Age-Related Differences in Health-Related Quality of Life in COPD: An Analysis of the COPDGene and SPIROMICS Cohorts. Chest. 2016 Apr; 149(4):927-35.
Score: 0.034
-
Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD. Ann Am Thorac Soc. 2015 Jan; 12(1):27-34.
Score: 0.031
-
Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials. Lancet Respir Med. 2013 May; 1(3):210-23.
Score: 0.028
-
Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology. 2011 Oct; 261(1):274-82.
Score: 0.025
-
Racial differences in quality of life in patients with COPD. Chest. 2011 Nov; 140(5):1169-1176.
Score: 0.025
-
Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction. Int J Chron Obstruct Pulmon Dis. 2010 Feb 18; 5:1-10.
Score: 0.022